ClinicalTrials.gg
Not yet recruitingNCT07890792Updated Oct 26, 2026

Health Care Professionals Diet App Study

An interventional study of MyDiet App in Nutrition Education, sponsored by University of Alberta. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University of Alberta · Not applicable, Interventional, and Supportive care

Updated Oct 26, 2026Primary outcomes revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate MyDiet, a nutrition education app designed to improve nutrition knowledge among healthcare providers. In this randomized trial, participants will be assigned to one of two groups: an intervention group or a control crossover group. Participants in the intervention group will have access to the app for two months, while those in the control crossover group will receive access during the second month of their participation.

The study will evaluate whether the app improves nutrition knowledge, has the potential to influence dietary behaviors, and supports healthcare providers in strengthening their ability to provide nutrition-related advice to their patients.

Read the detailed description

This is a two-month long study evaluating MyDiet App for it's potential in improving nutrition knowledge. In this study, there are two arms : Intervention Arm (accesses the app for the entire duration of the study i.e. 2 months) and the Control Crossover Arm (accessed the app for the latter half of the study ). There will be three visits ( Baseline, Month 1 and Month 2).

At each of these visits, following study procedures will be conducted:

Visit 1 (Baseline): This will be about 30 minutes long. Participants will complete a demographics questionnaire, medical history and anthropometrics (weight, height, waist circumference). They will also complete the Canadian Behavior, Attitude and Nutrition Knowledge Survey 2.0 (C-BANKS 2.0). Participants in the intervention arm will receive access to the app.

Visit 2 (Month 1): This will be about 30 minutes long as well. Participants will complete anthropometrics, C-BANKS 2.0. Participants in the intervention arm will also complete the mHealth App Usability Questionnaire (mAUQ), Theoretical Framework of Acceptability (TFA) questionnaire, and ABACUS App Behavior Change Tool. Participants in the Control Crossover Arm will get access to the app.

Visit 3 (Month 2): This will be about 30 minutes long. Participants will complete C-BANKS 2.0 survey, mAUQ, TFA, ABACUS. At each visit, participants will also complete a 3-day food recall. Optional: Participants will be provided with an option to provide a blood and stool sample for metabolomics and microbial analyses, and a urine sample to measure sodium and chloride levels as an indirect estimate of ultra-processed food intake. If they agree, the samples will be collected at each visit.

02

Conditions studied

  • Nutrition Education
03

In context

Lead sponsor

University of Alberta is the lead sponsor of 819 studies on the registry; 166 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. ≥18 years
  2. Able to provide informed consent
  3. Health care providers (physicians, nurses, dietitians, health care administrative staff, interns, residents) or students (medical, dietetics, nursing and other branches)
  4. Not pregnant
  5. Willing and able to comply with all required study procedures

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy or breastfeeding
  2. Diagnosis of chronic conditions require specialized dietary care like Celiac disease, etc.
  3. Enrolled in a therapeutic diet program or study
  4. Active malignancy
  5. Malnutrition (as per CNST)
  6. Eating disorder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    gets access to the app for the entire duration of the study (2 months)

    Behavioral: MyDiet App

  • Active comparator
    Control Crossover Arm

    gets access to the app for the second month of their participation

    Behavioral: MyDiet App

Interventions

  • BehavioralMyDiet App

    MyDiet App is a nutrition guidance app designed to support self-management of diet and nutrition. The app provides immediate feedback on nutrition parameters like level of food processing and adherence to a mediterranean style of eating for food items logged.

06

What researchers measure

Primary outcomes

  1. Nutrition Knowledge

    Change in nutrition knowledge as assessed by change in Canadian Behavior, Attitude and Nutrition Knowledge Survey (C-BANKS 2.0) survey scores from baseline to end of month 1 between intervention and control crossover group. The C-BANKS 2.0 Survey score ranges from 14.3 to 100, where higher scores indicate higher nutrition knowledge.

    Time frame: 1 month

Secondary outcomes

  1. Nutrition Knowledge

    Within group change in C-BANKS 2.0 survey scores from baseline to end of month 2 in the intervention group. The C-BANKS 2.0 Survey score ranges from 14.3 to 100, where higher scores indicate higher nutrition knowledge.

    Time frame: 2 months

  2. Nutrition Knowledge

    Within group change in C-BANKS 2.0 survey scores from end of month 1 to end of month 2 in the control crossover group. The C-BANKS 2.0 Survey score ranges from 14.3 to 100, where higher scores indicate higher nutrition knowledge.

    Time frame: 1 month

  3. Diet Quality

    Change in diet quality as assessed using Health Eating Index (HEI) pre and post intervention in control crossover group. The HEI score ranges from 0 to 100, where higher scores indicate better diet quality.

    Time frame: 1 month

  4. Diet Quality

    Change in diet quality as assessed using Health Eating Index (HEI) pre and post intervention in intervention group. The HEI score ranges from 0 to 100, where higher scores indicate better diet quality.

    Time frame: 2 months

  5. Diet Quality

    Change in diet quality as assessed using Health Eating Index (HEI) between intervention and control crossover group at the end of month 1. The HEI score ranges from 0 to 100, where higher scores indicate better diet quality.

    Time frame: 1 month

  6. Intake of ultra-processed foods

    Change in intake of ultra-processed foods as assessed using food records data from the app and using NOVA classification over time in the intervention group.

    Time frame: 2 months

  7. Intake of ultra-processed foods

    Change in intake of ultra-processed foods as assessed using food records data from the app and using NOVA classification over time in the control crossover group

    Time frame: 2 months

  8. Intake of ultra-processed foods

    Change in intake of ultra-processed foods as assessed using food records data from the app and using NOVA classification between the intervention and control crossover group at the end of month 1

    Time frame: 1 month

  9. App's potential to change behavior

    Assessed using the ABACUS app behavior change scale at the end of intervention. The ABACUS scale scores range from 0 to 21, where higher scores indicate higher behavior change potential.

    Time frame: At the end of 2 months

  10. Usability of the app

    Assessed using the mAUQ questionnaire at the end of participation in the study after starting intervention. The 18-items on this questionnaire are scored on a likert scale of 1 to 7, where higher scores indicate better usability.

    Time frame: Anytime in 2 months based on end of participation.

  11. Acceptability

    Assessed using the TFA questionnaire at the end of participation in the study after starting intervention. The 8-items on this questionnaire are scored on a likert scale of 1 to 5, where higher scores indicate better acceptability.

    Time frame: Anytime in 2 months based on end of participation

  12. Adherence to Mediterranean diet

    Assessed using the mediterranean diet serving score (MDSS) over time in the intervention group. MDSS score ranges from 0 to 24 , where a higher score indicates better adherence to mediterranean pattern of eating.

    Time frame: 2 months

  13. Adherence to Mediterranean diet

    Assessed using the mediterranean diet serving score (MDSS) over time in the control crossover group. MDSS score ranges from 0 to 24 , where a higher score indicates better adherence to mediterranean pattern of eating.

    Time frame: 2 months

  14. Adherence to Mediterranean diet

    Assessed using the mediterranean diet serving score (MDSS), change in MDSS score compared between the intervention and control crossover group at the end of month 1. MDSS score ranges from 0 to 24 , where a higher score indicates better adherence to mediterranean pattern of eating.

    Time frame: 1 month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2026
First posted
Oct 22, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Nov 1, 2027
CompletionEst.
Apr 30, 2028
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
primary outcomes
Registered
First appeared on the registry
Oct 22, 2026
Show all 2 updates
  1. Oct 26, 2026
    Primary outcomes Revised (1 change)
    + 3 other changes: description, arm descriptions and secondary outcomes
  2. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07890792
Responsible party
Sponsor
First posted
Oct 22, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 1, 2027 (estimated)
Completion
Apr 30, 2028 (estimated)
Last update
Oct 26, 2026

Study contacts

Karen Wong, MD, FRCPC
Contact
kwong3@ualberta.ca
780-492-8691 ext. Ext 5
Ravneet Kaur, M.Sc.
Contact
rkaur8@ualberta.ca
7802481034

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion